Skip to main content

The Broad Ligament Fibroid

  • Chapter
  • First Online:
Uterine Fibroids

Abstract

Although broad ligament myomas are the most common of the extrauterine myomas, they are rare, with an incidence of approximately 1%. Their location can cause unusual presentations and potentially compromise the accuracy of a preoperative diagnosis. Because the location is peculiar due to the complex anatomy in this region (i.e., ureters and internal iliac and obturator vessels and nerves), the surgeon must pay close attention during dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of uterine myomas: a review. Int J Fertil Steril. 2016;9(4):424–35.

    PubMed  Google Scholar 

  2. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995;172(1 Pt 1):14–8.

    Article  CAS  PubMed  Google Scholar 

  3. Andersen J. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol. 1996;14(3):269–82.

    Article  CAS  PubMed  Google Scholar 

  4. Fields KR, Neinstein LS. Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol. 1996;9(4):195–8.

    Article  CAS  PubMed  Google Scholar 

  5. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–8.

    Article  CAS  PubMed  Google Scholar 

  6. Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005;48(2):312–24.

    Article  PubMed  Google Scholar 

  7. Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril. 2003;80(6):1488–94.

    Article  PubMed  Google Scholar 

  8. Sparic R, Hudelist G, Berisavac M, Gudovic A, Buzadzic S. Hysterectomy throughout history. Acta Chir Iugosl. 2011;58(4):9–14.

    Article  PubMed  Google Scholar 

  9. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol. 2002;99(2):229–34.

    PubMed  Google Scholar 

  10. Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14(1):CR24–31.

    PubMed  Google Scholar 

  11. Lurie S, Piper I, Woliovitch I, Glezerman M. Age-related prevalence of sonographically confirmed uterine myomas. J Obstet Gynaecol. 2005;25:42–8.

    Article  CAS  PubMed  Google Scholar 

  12. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009;113(3):630–5.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chen CR, Buck GM, Courey NG, Perez KM, Wactawski-Wende J. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol. 2001;153(1):20–6.

    Article  CAS  PubMed  Google Scholar 

  14. Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstet Gynecol Scand. 2000;79(3):202–7.

    Article  CAS  PubMed  Google Scholar 

  15. Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, Olive D. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod. 2004;19(10):2350–5.

    Article  CAS  PubMed  Google Scholar 

  16. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the black Women’s health study. Obstet Gynecol. 2005;105:563–8.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age of diagnosis. J Reprod Med. 1996;41:483–90.

    CAS  PubMed  Google Scholar 

  18. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives [Published correction appears in Br Med J (Clin Res Ed) 1986;293:1027]. Br Med J (Clin Res Ed). 1986;293:359–62.

    Article  CAS  Google Scholar 

  19. Ligon AH, Morton CC. Leiomyomata: heritability and cytogenetic studies. Hum Reprod Update. 2001;7:8–14.

    Article  CAS  PubMed  Google Scholar 

  20. Chiaffarino F, Parazzini F, La Vecchia C, Marsico S, Surace M, Ricci E. Use of oral contraceptives and uterine fibroids: results from a case-control study. Br J Obstet Gynaecol. 1999;106:857–60.

    Article  CAS  PubMed  Google Scholar 

  21. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhika-mraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol. 1996;103:909–14.

    Article  CAS  PubMed  Google Scholar 

  22. Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002.

    Google Scholar 

  23. Pallavee P, Ghose S, Begum J, et al. Fibroid after hysterectomy: diagnostic dilemma. J Clin Diagn Res. 2014;8:1–3.

    Article  Google Scholar 

  24. Bhatla N. Tumours of the corpus uteri. Jeffcoats principles of gynaecology. 6th ed. London: Arnold Printers; 2001. p. 470.

    Google Scholar 

  25. Harrison BT, Berg RE, Mittal K. Massive ovarian edema associated with a broad ligament leiomyoma: a case report and review. Int J Gynecol Pathol. 2014;33:418–22.

    Article  PubMed  Google Scholar 

  26. Song JY. Laparoscopic resection of a rare, large broad ligament myoma. J Minim Invasive Gynecol. 2015;22(4):530–1.

    Article  PubMed  Google Scholar 

  27. Amant F, Coosemans A, Debiec-Rychter M, et al. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10:1188.

    Article  PubMed  Google Scholar 

  28. Schwartz LB, Zawin M, Carcangiu ML, et al. Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril. 1998;70:580.

    Article  CAS  PubMed  Google Scholar 

  29. Goto A, Takeuchi S, Sugimura K, et al. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer. 2002;12:354.

    Article  CAS  PubMed  Google Scholar 

  30. Tanaka YO, Nishida M, Tsunoda H, et al. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging. 2004;20:998.

    Article  PubMed  Google Scholar 

  31. Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100.

    Article  PubMed  Google Scholar 

  32. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol. 2004;93:204.

    Article  PubMed  Google Scholar 

  33. Fang Z, Matsumoto S, Ae K, et al. Postradiation soft tissue sarcoma: a multi-institutional analysis of 14 cases in Japan. J Orthop Sci. 2004;9(3):242.

    Article  PubMed  Google Scholar 

  34. Giuntoli RL 2nd, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89(3):460.

    Article  PubMed  Google Scholar 

  35. Wickerham DL, Fisher B, Wolmark N, et al. Association of Tamoxifen and uterine sarcoma. J Clin Oncol. 2002;20:2758.

    Article  PubMed  Google Scholar 

  36. Wysowski DK, Honig SF, Beitz J. Uterine sarcoma associated with tamoxifen use. N Engl J Med. 2002;346:1832.

    Article  PubMed  Google Scholar 

  37. Moinfar F, Azodi M, Tavassoli FA. Uterine sarcomas. Pathology. 2007;39:55.

    Article  PubMed  Google Scholar 

  38. Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A. 2001;98(6):3387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73(1):95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. CL Y, Tucker MA, Abramson DH, et al. Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst. 2009;101(8):581.

    Article  Google Scholar 

  41. Sener AB, Seçkin NC, Ozmen S, et al. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women. Fertil Steril. 1996;65(2):354.

    Article  CAS  PubMed  Google Scholar 

  42. Polatti F, Viazzo F, Colleoni R, et al. Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT. Maturitas. 2000;37(1):27.

    Article  CAS  PubMed  Google Scholar 

  43. Ang WC, Farrell E, Vollenhoven B. Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review. Climacteric. 2001;4(4):284.

    Article  CAS  PubMed  Google Scholar 

  44. Yang CH, Lee JN, Hsu SC, et al. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women—a 3-year study. Maturitas. 2002;43(1):35.

    Article  CAS  PubMed  Google Scholar 

  45. Song JY. Laparoscopic resection of the large broad ligament fibroid. Washington, D.C.: Surgical video session presented at the meeting of the American Association of Gynecologic Laparoscopists; 2013.

    Google Scholar 

  46. Hasson HM, Rotman C, Rana N, et al. Open laparoscopy: 29-year experience. Obstet Gynecol. 2000;96(5 P 1):763–6.

    CAS  PubMed  Google Scholar 

  47. Hasson HM, Rotman C. Laparoscopic myomectomy. In: Sanfilippo JS, Levine RL, editors. Operative gynecologic endoscopy. 2nd ed. New York: Springer; 1996. p. 89–103.

    Chapter  Google Scholar 

  48. Song JY, Borncamp E, Mehaffey P, Rotman C. Large abdominal wall endometrioma following laparoscopic hysterectomy. JSLS. 2011;15(2):261–3.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Rotman C, Rana N, Song JY, et al. Laparoscopic tubal anastomosis. In: Rizk B, Garcia-Velasco J, Sallam H, Makrigiannakis A, editors. Infertility and assisted reproduction. Cambridge: Cambridge University Press; 2008. p. 91–8.

    Chapter  Google Scholar 

  50. Kashani BN, Centini G, Morelli S, et al. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016;34:85–103.

    Article  PubMed  Google Scholar 

  51. Conforti A, Mollo A, Alviqqi C, et al. Techniques to reduce blood loss during open myomectomy: a qualitative review of literature. Eur J Obstet Gynecol Reprod Biol. 2015;192:90–5.

    Article  PubMed  Google Scholar 

  52. Zhang Y, Sun L, Guo Y, et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis. Obstet Gynecol Surv. 2014;69(2):100–8.

    Article  PubMed  Google Scholar 

  53. Bassaw B, Mohammed N, Jaqqat A, et al. Experience with a gonadotropin-releasing hormone agonist prior to myomectomy-comparison of twice vs. thrice monthly doses and a control group. J Obstet Gynaecol. 2014;34(5):415–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan Y. Song MD, FACOG, FACS .

Editor information

Editors and Affiliations

Electronic Supplementary Material

(MP4 139573 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Song, J.Y., Rotman, C., Yordan, E.L. (2018). The Broad Ligament Fibroid. In: Moawad, N. (eds) Uterine Fibroids. Springer, Cham. https://doi.org/10.1007/978-3-319-58780-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58780-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58779-0

  • Online ISBN: 978-3-319-58780-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics